1. Home
  2. ATOM vs AVTX Comparison

ATOM vs AVTX Comparison

Compare ATOM & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atomera Incorporated

ATOM

Atomera Incorporated

HOLD

Current Price

$2.35

Market Cap

68.7M

Sector

Technology

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$18.99

Market Cap

248.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOM
AVTX
Founded
2001
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
248.3M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
ATOM
AVTX
Price
$2.35
$18.99
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$32.29
AVG Volume (30 Days)
445.4K
341.4K
Earning Date
02-10-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$38,000.00
$192,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.89
$3.39
52 Week High
$17.55
$20.72

Technical Indicators

Market Signals
Indicator
ATOM
AVTX
Relative Strength Index (RSI) 44.07 53.63
Support Level $2.18 $17.18
Resistance Level $2.48 $20.20
Average True Range (ATR) 0.20 1.60
MACD 0.02 -0.06
Stochastic Oscillator 27.27 59.35

Price Performance

Historical Comparison
ATOM
AVTX

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: